Why the study?
Does aliskiren alone or combined with valsartan improve diabetic nephropathy in db/db mice?
Does aliskiren alone or combined with valsartan improve diabetic nephropathy in db/db mice?
Aliskiren provides protective effects against type 2 diabetic nephropathy and enhances the protective effects of valsartan in a mouse model.
Answers are grounded in this paper and cite their sources.
Supports additive renoprotection in diabetic mouse models; leaves open clinical translation and human trials.
OBJECTIVES: Addition of aliskiren, a direct renin inhibitor, to losartan provides additive reduction of urinary albumin excretion in type 2 diabetic patients. However, the detailed effect of aliskiren on type 2 diabetic nephropathy is still unknown. This study was undertaken to examine the efficacy of aliskiren and the combination of aliskiren with valsartan on type 2 diabetic nephropathy. METHODS: db/db mice were treated with aliskiren (3 mg/kg per day), valsartan (5 or 10 mg/kg per day), combined aliskiren (3 mg/kg per day) and valsartan (5 mg/kg per day), and hydralazine (80 mg/kg per day), for 6 weeks, and the protective effects against diabetic nephropathy were compared among each group. RESULTS: Aliskiren significantly attenuated albuminuria and glomerular mesangial matrix expansion in db/db mice, which was associated with the improvement of the increased glomerular transforming growth factor-beta and type IV collagen expressions, the increased macrophage infiltration, and the decreased glomerular nephrin expression of db/db mice. These protective effects of aliskiren in db/db mice were attributed to the attenuation of p22(phox)-related nicotinamide adenine dinucleotide phosphate oxidase-induced superoxide. Addition of aliskiren to valsartan treatment provided more beneficial effects on all the above-mentioned parameters than valsartan monotherapy. CONCLUSION: Aliskiren protected against type 2 diabetic nephropathy, through pleiotropic effects, and significantly enhanced the protective effects of valsartan against diabetic nephropathy in db/db mice.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: